EurekaMag.com logo
+ Translate

Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?


, : Can the response to interferon treatment be predicted in patients with chronic active hepatitis C?. Australian and New Zealand Journal of Medicine 21(3): 387-392

Chronic hepatitis C infection can be suppressed by alpha -interferon, and about 20% of patients will be cured by 6 or more months' therapy. In this study of such treatment, response in terms of both short-term reduction of aminotransferase activity and long-term remission was most likely in those with mild liver disease and after acquisition by drug abuse rather than other sources. This contrasts with hepatitis B where responders generally have more severe liver disease.M.G.

(PDF 0-2 workdays service)

Accession: 002042369

PMID: 1953524

Submit PDF Full Text: Here


Submit PDF Full Text

No spam - Every submission is manually reviewed

Due to poor quality, we do not accept files from Researchgate

Submitted PDF Full Texts will always be free for everyone
(We only charge for PDFs that we need to acquire)

Select a PDF file:
Close
Close

Related references

Cimino, T.; Leggieri, A.; D.R.sa, G.; Bertucci, R., 1993: Histologic forms of chronic hepatitis and response to interferon treatment. Clinical effectiveness of interferon alpha and beta treatment compared with chronic active viral hepatitis of various histologic grades. The authors evaluated the clinical response to treatment with interferons in relation to chronic virulent hepatitis, different on histological level. All the interferons until now commercially available have been employed following a casual standa...

Coverdale, S.; Byth, K.; Field, J.; Liddle, C.; Lin, R.; Farrell, G.C., 1995: Antipyrine clearance and response to interferon treatment in patients with chronic active hepatitis C. To determine whether hepatic metabolic function affects the response to interferon treatment, we measured antipyrine clearance (APC) in 85 patients with chronic active hepatitis C and compared the results with treatment outcome. Among 55 patients...

Coverdale, S.; Byth, K.; Field, J.; Liddle, C.; Lin, R.; Farrell, G.C., 1995: Antipyrine clearance and response to interferon treatment in patients with chronic active hepatitis C. To determine whether hepatic metabolic function affects the response to interferon treatment, we measured antipyrine clearance (APC) in 85 patients with chronic active hepatitis C and compared the results with treatment outcome. Among 55 patients...

Valle, D.; Rapaccini, G.L.; Puglisi, L.; Pompili, M.; Mancini, A.; Marino, P.; D.M.rinis, L.; Gasbarrini, G., 1997: Leucocitary alpha-interferon treatment reduces GHRH-induced GH response in patients with chronic active hepatitis. Journal of Hepatology 26(SUPPL 1): 308

Rocca, G.; Saracco, G.; Ciancio, A.; Ghisetti, V.; Cariti, G.; Andreoni, M.; Tabone, M.; Roffi, L.; Calleri, G.; Ballare', M.; Rizzetto, M., 1999: Non response to interferon monotherapy can be predicted by probabilistic neural networks in naive patients with chronic hepatitis C. Hepatology 30(4 PART 2): 370A, Oct

De-Lazzari, F.; De-Silvestro, G.; Floreani, A.; Fabris, P.; Chiaramonte, M.; Ongaro, G.; Naccarato, R., 1995: Recombinant-alpha-2b-interferon treatment in patients with chronic active hepatitis: Effects on peripheral blood mononuclear cells and correlation with response. The purpose of this study was to evaluate the relationship between peripheral blood monocyte and lymphocyte subsets and response to recombinant-alpha-2b-interferon (r-alpha-2b-IFN) in patients with viral chronic active hepatitis (CAH). Peripheral...

Areias, I.; Pedroto, I.; Preitas, T.; Cerquiera, R.; Pinoho, I.; Justica, B.; Saraiva, A.M., 1996: HCV viremia, genotypic analysis and response to interferon-alpha-2b treatment in patients with chronic active hepatitis C co-infected with the human immunodeficiency virus. Gastroenterology 110(4 SUPPL ): A1143

Molloy, J.; Kania, R.; Friedland, L.; Van Thiel, D., 1993: Interferon treatment of chronic viral hepatitis C in patients with co-existent autoimmune chronic active hepatitis. Hepatology 18(4 PART 2): 244A

Niederau, C.; Heintges, T.; Niederau, M.; Stremmel, W.; Strohmeyer, G., 1992: Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B. A randomized controlled trial was conducted to prospectively compare the efficacy of sequential treatment with corticoids and alpha-interferon versus treatment with interferon (IFN) alone in patients with chronic hepatitis B. Sixty patients with c...

Vlach, H.A.; Johnson, S.P., 1988: Interferon production in patients with chronic active hepatitis b during treatment with recombinant interferon alpha. Journal of Hepatology 7: S72